Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
Ensysce Biosciences reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
Ensysce Biosciences reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, three executives at Ensysce Biosciences received on average a compensation package of $236K, a 105% increase compared to previous year.
Average pay of disclosed executives at Ensysce Biosciences
Lynn Kirkpatrick, Chief Executive Officer, received $288K in total, which increased by 85% compared to 2020. 60% of Kirkpatrick's compensation, or $174K, was in salary. Kirkpatrick also received $114K in bonus.
David Humphrey, Chief Financial Officer, received a compensation package of $284K. 66% of the compensation package, or $188K, was in salary.
Geoff Birkett, Chief Commercial Officer, earned $135K in 2021, a 88% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 2, 2022.